Ashfield Capital Partners’s Teladoc Health TDOC Stock Holding History

Ashfield Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33,810	Closed	-$5.62M	–	234
2021 Q2	$5.62M	Sell	33,810 -43	-0.1%	-$6.97K	0.4%	64
2021 Q1	$6.15M	Buy	33,853 +579	+2%	+$134K	0.49%	56
2020 Q4	$6.65M	Buy	33,274 +5,730	+21%	+$1.17M	0.54%	50
2020 Q3	$6.04M	Buy	+27,544	New	+$5.83M	0.55%	53

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Ashfield Capital Partners's TDOC Position: Q3 2021 in Review

Ashfield Capital Partners sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 33,810 shares — an estimated $5.62M sold.

Ashfield Capital Partners first reported a position in TDOC in Q3 2020 and held it in 4 quarters. The position peaked at $6.65M in Q4 2020. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

Ashfield Capital Partners reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
Ashfield Capital Partners sold 33,810 Teladoc Health shares in Q3 2021, an estimated $5.62M.
Ashfield Capital Partners first reported a position in Teladoc Health in Q3 2020 and held it in 4 quarters.
Ashfield Capital Partners's Teladoc Health position peaked at $6.65M in Q4 2020.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on Ashfield Capital Partners's 13F filing for Q3 2021, filed 9 Nov 2021.